PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2023 | $1,341,333 | -71.3% | 74,025 | -57.9% | 0.01% | -75.0% |
Q1 2023 | $4,678,275 | +214.0% | 175,875 | +128.2% | 0.02% | +150.0% |
Q4 2022 | $1,489,763 | +165.1% | 77,070 | +186.5% | 0.01% | +166.7% |
Q3 2022 | $562,000 | +420.4% | 26,901 | +99.9% | 0.00% | +200.0% |
Q2 2022 | $108,000 | – | 13,459 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 5,839,160 | $98,565,000 | 18.71% |
CHI Advisors LLC | 2,484,724 | $41,942,000 | 12.24% |
TRV GP IV, LLC | 2,132,867 | $36,003,000 | 8.17% |
Bond & Devick Financial Network, Inc. | 120,160 | $2,028,000 | 1.68% |
Fernwood Investment Management, LLC | 166,447 | $2,810,000 | 0.96% |
Redmile Group, LLC | 3,083,501 | $52,049,000 | 0.91% |
HARVARD MANAGEMENT CO INC | 562,379 | $9,493,000 | 0.56% |
Grace Capital | 48,058 | $808,000 | 0.50% |
Eventide Asset Management | 2,183,238 | $36,853,000 | 0.49% |
Cormorant Asset Management, LP | 482,413 | $8,143,000 | 0.33% |